Leave a comment and click here to sub for MS Equity Analysis and Swing Moves. Overview Trevena Inc. (Nasdaq: TRVN) is set to present tomorrow February 12 at 9:15 EST at the 21st Annual BIO CEO & … [Read more...] about TRVN to Present at BIO & CEO Conference
Introduction Trevena Inc. (Nasdaq: TRVN) spiked 119% from the $.5 range to $1.19 on January 28th. The catalyst being positive regulatory updates from the FDA Type A meeting minutes. In a … [Read more...] about 2019 Should Be A Good Year For TRVN, But What’s Next?
MS Money Moves Swing thesis for AcelRX Pharma (ACRX) published last week in our "Swing Alert"article played out nicely. ACRX spiked ~70% from $2.90 to $4.92 in the last 5 trading sessions. The upward … [Read more...] about ACRX to Spike Monday off Favorable ADCOM Vote 10-3: How to Handle It
GALT’s phase 3 study inclusion criteria will be patients diagnosed with NASH-cirrhosis but without varices, and includes an interim analysis. Competition in the NASH-cirrhosis space is lacking. The … [Read more...] about Galectin Blocker is Front Runner in Fight Against NASH-Cirrhosis
Overview Swing Trading is a trading strategy that involves buying a stock at a lower price and selling it at a higher price over a short period of time. Return on investment targets ranges from … [Read more...] about Swing Trading a Biotech Stock